Related references
Note: Only part of the references are listed.Elite Controllers with Low to Absent Effector CD8+ T Cell Responses Maintain Highly Functional, Broadly Directed Central Memory Responses
Zaza M. Ndhlovu et al.
JOURNAL OF VIROLOGY (2012)
Cytotoxic CD4+ T Cell Responses to EBV Contrast with CD8 Responses in Breadth of Lytic Cycle Antigen Choice and in Lytic Cycle Recognition
Heather M. Long et al.
JOURNAL OF IMMUNOLOGY (2011)
Post-transplant lymphoproliferative disorders and Epstein-Barr virus DNAemia in a cohort of lung transplant recipients
Fausto Baldanti et al.
VIROLOGY JOURNAL (2011)
Expansion of EBNA1-specific effector T cells in posttransplantation lymphoproliferative disorders
Kimberley Jones et al.
BLOOD (2010)
Optimization of a dendritic cell-based assay for the in vitro priming of naive human CD4+ T cells
Janice M. Moser et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2010)
The relationship between human effector and memory T cells measured by ex vivo and cultured ELISPOT following recent and distal priming
Stephen M. Todryk et al.
IMMUNOLOGY (2009)
Epitope Specificity and Clonality of EBV-Specific CTLs Used to Treat Posttransplant Lymphoproliferative Disease
Karen A. McAulay et al.
JOURNAL OF IMMUNOLOGY (2009)
Precision and linearity targets for validation of an IFNγ ELISPOT, cytokine flow cytometry, and tetramer assay using CMV peptides
Holden T. Maecker et al.
BMC IMMUNOLOGY (2008)
Kinetics of Epstein-Barr Virus DNA Load in Different Blood Compartments of Pediatric Recipients of T-Cell-Depleted HLA-Haploidentical Stem Cell Transplantation
Fausto Baldanti et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
HIV-1-specific T cell precursors with high proliferative capacity correlate with low viremia and high CD4 counts in untreated individuals
Sandra A. Calarota et al.
JOURNAL OF IMMUNOLOGY (2008)
Repertoire and frequency of immune cells reactive to Epstein-Barr virus-derived autologous lymphoblastoid cell lines
Sumita Bhaduri-McIntosh et al.
BLOOD (2008)
A quantitative assay for Epstein-Barr virus-specific immunity shows interferon-γ producing CD8+T cells increase during immunosuppression reduction to treat posttransplant lymphoproliferative disease
Amy E. Guppy et al.
TRANSPLANTATION (2007)
Immunodominance of Lytic Cycle Antigens in Epstein-Barr Virus-Specific CD4+T Cell Preparations for Therapy
Dinesh Adhikary et al.
PLOS ONE (2007)
Distinct memory CD4+ T-cell subsets mediate immune recognition of Epstein Barr virus nuclear antigen 1 in healthy virus carriers
Kevin N. Heller et al.
BLOOD (2007)
Region of difference 1 antigen-specific CD4+ memory T cells correlate with a favorable outcome of tuberculosis
Delia Goletti et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Correlation of antiviral T-cell responses with suppression of viral rebound in chronic hepatitis B carriers: a proof-of-concept study
S-H Yang et al.
GENE THERAPY (2006)
Loss of EBNA1-specific memory CD4+ and CD8+ T cells in HIV-infected patients progressing to AIDS-related non-hodgkin lymphoma
E Piriou et al.
BLOOD (2005)
Durable human memory T cells quantifiable by cultured enzyme-linked immunospot assays are induced by heterologous prime boost immunization and correlate with protection against malaria
SM Keating et al.
JOURNAL OF IMMUNOLOGY (2005)
Human CD4+ T cells are predominantly distributed among six phenotypically and functionally distinct subsets
E Amyes et al.
JOURNAL OF IMMUNOLOGY (2005)
EBV-specific memory CD8+ T cell phenotype and function in stable solid organ transplant patients
C Macedo et al.
TRANSPLANT IMMUNOLOGY (2005)
Novel method for detection of virus-specific CD4+ T cells indicates a decreased EBV-specific CD4+ T cell response in untreated HIV-infected subjects
ER Piriou et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
Analysis of antigen-specific T-Cell responses with synthetic peptides - What kind of peptide for which purpose?
F Kiecker et al.
HUMAN IMMUNOLOGY (2004)
Quantitative analysis of Epstein-Barr virus (EBV)-specific CD8+ T cells in patients with chronic active EBV infection
N Sugaya et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Self-inhibition of synthesis and antigen presentation by Epstein-Barr virus-encoded EBNA1
Y Yin et al.
SCIENCE (2003)
CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes
EM Janssen et al.
NATURE (2003)
Cytolytic CD4(+)-T-Cell clones reactive to EBNA1 inhibit Epstein-Barr virus-induced B-Cell proliferation
S Nikiforow et al.
JOURNAL OF VIROLOGY (2003)
The evolution of antigen-specific CD8(+) T cell responses after natural primary infection of humans with Epstein-Barr virus
MFC Callan
VIRAL IMMUNOLOGY (2003)
Inhibition of EBV-induced lymphoproliferation by CD4+ T cells specific for an MHC class II promiscuous epitope
R Omiya et al.
JOURNAL OF IMMUNOLOGY (2002)
Ratio between Epstein-Barr viral load and anti-Epstein-Barr virus specific T-cell response as a predictive marker of posttransplant lymphoproliferative disease
F Smets et al.
TRANSPLANTATION (2002)
A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays
JR Currier et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2002)
Use of overlapping peptide mixtures as antigens for cytokine flow cytometry
HT Maecker et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2001)
Differential immunogenicity of Epstein-Barr virus latent-cycle proteins for human CD4+ T-helper 1 responses
A Leen et al.
JOURNAL OF VIROLOGY (2001)
EBV-Specific CD8+ T cell memory:: Relationships between epitope specificity, cell phenotype, and immediate effector function
AD Hislop et al.
JOURNAL OF IMMUNOLOGY (2001)
Human CD4+ T lymphocytes consistently respond to the latent Epstein-Barr virus nuclear antigen EBNA1
C Münz et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Share Paper
